Nutritional supplements in the management of polycystic ovary syndrome. Literature review
Keywords:
Polycystic ovary syndrome, Vitamin D, Omega 3, Bacterial microbiotaAbstract
Polycystic ovary syndrome is a chronic endocrine disorder that affects women of reproductive age. It is characterized by anovulation, hyperandrogenism, and insulin resistance, which increases hyperinsulinemia and affects lipid metabolism, thereby increasing the risk of ovarian cysts and hormonal disturbances. Nutritional supplements are emerging as novel adjuvant treatment techniques for women diagnosed with this syndrome. The aim of this article is to conduct a literature review of the last 5 years of articles published in the PubMed, Scopus, Web of Science, and ScieLO databases associated with this topic. A documentary review was used to collect information. The main finding was that nutritional supplements play a key role in the management of this disease. Myo-inositol improves insulin sensitivity, regulates the menstrual cycle, and improves egg quality; vitamin D and calcium act on menstrual regularity and follicular development; omega-3 fatty acids reduce insulin resistance and improve the lipid profile; and finally, there is evidence of decreased microbiota in women with PCOS. Although there is consensus on the potential benefits of certain supplements in the management of PCOS, opinions vary regarding their relative efficacy and optimal combinations, so further studies are needed.
Downloads
References
Aguaviva Bascuñana, J. J. y Olivares Sánchez, N. (2024). Intervenciones dietéticas en el tratamiento del síndrome del ovario poliquístico. Una revisión bibliográfica. Rev. Clínica e Investigación en Ginecología y Obstetricia, 51(1), 100911. https://doi.org/10.1016/j.gine.2023.100911
Albardan, L., Platat, C., & Kalupahana, N. S. (2024). Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome. Nutrients, 16(17), 2961. https://doi.org/10.3390/nu16172961
Al Wattar, BH., Fisher, M., Bevington, L., Talaulikar, V., Davies, M., Conway, G. & Yasmin, E. (2021) Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study. The Journal of Clinical Endocrinology & Metabolism, 106(8), 2436–46. https://doi.org/10.1210/clinem/dgab232
Antón, A. A. (2024). Efecto y comparación de la dieta cetogénica, mediterránea y de bajo índice glucémico en el tratamiento del síndrome de ovario poliquístico (SOP). MLS Health and Nutrition Research, 3(2), 132-147. https://doi.org/10.60134/mlshn.v3n1.2906
Calcaterra, V., Rossi, V., Massini, G., Casini, F., Zuccotti, G., & Fabiano, V. (2023). Probiotics and Polycystic Ovary Syndrome: A Perspective for Management in Adolescents with Obesity. Nutrients, 15(14), 3144. https://doi.org/10.3390/nu15143144
Carrasco-Cabezas, M., Assmann, T. S., Martínez, P., Cerpa, L., Calfunao, S., Echiburú, B., Maliqueo, M., Crisosto, N., & Salas-Pérez, F. (2024). Folate and Vitamin B12 Levels in Chilean Women with PCOS and Their Association with Metabolic Outcomes. Nutrients, 16(12), 1937. https://doi.org/10.3390/nu16121937
Chu, W., Han Q., Xu J., Wang J., Sun Y., Li W., Chen Z.-J., Du Y. (2020). Metagenomic Analysis Identified Microbiome Alterations and Pathological Association between Intestinal Microbiota and Polycystic Ovary Syndrome. Fertil. Steril. 113, 1286–1298.e4. 10.1016/j.fertnstert.2020.01.027
Delgado, E. P., Vega, D. F. & Prieto, C. F. (2024). Efectos de la Suplementación con Vitamina D en Mujeres de Edad Fértil con Ovario Poliquístico y Resistencia a la Insulina: Revisión Sistemática. Ciencia Latina Revista Científica Multidisciplinar, 8(5), 7569-7588. https://doi.org/10.37811/cl_rcm.v8i5.14166
Durack, J. y Lynch, S. V. (2019). The Gut Microbiome: Relationships with Disease and Opportunities for Therapy. J. Exp. Med. 216, 20-40. https://10.1084/jem.20180448
Han, Y., Hou, Y., Han, Q., Yuan, X. & Chen, L. (2024). Dietary supplements in polycystic ovary syndrome–current evidence. Front Endocrinol Sec Reproduction, 15. 1456571. https://doi.org/10.3389/fendo.2024.1456571
Igual Soria, V. (2024). Revisión bibliográfica sobre las terapias no farmacológicas en el manejo del síndrome de ovario poliquístico. [Tesis de grado. Facultad de Farmacia Universidad Miguel Hernández]. https://dspace.umh.es/bitstream/11000/32715/1/Igual%20Soria,%20Verónica.pdf
Irianto, C. B. & Prasetyadi, E. G. (2021). Coenzyme Q10 and/or Vitamin E Supplementation for Polycystic Ovarian Syndrome. CDK. 48(11). 361-364. https://doi.org/10.55175/cdk.v48i11.150
Li, R., Li, Z., Huang, Y., Hu, K., Ma, B., & Yang, Y. (2022). The effect of magnesium alone or its combination with other supplements on the markers of inflammation, OS and metabolism in women with polycystic ovarian syndrome (PCOS): A systematic review. Frontiers in endocrinology, 13, 974042. https://doi.org/10.3389/fendo.2022.974042
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019). Lifestyle changes in women with polycystic ovary syndrome. The Cochrane database of systematic reviews, 3(3), CD007506. https://doi.org/10.1002/14651858.CD007506.pub4
Mammadova, G., Ozkul, C., Yilmaz Isikhan, S., Acikgoz, A. y Yildiz, B. O. (2021). Characterization of Gut Microbiota in Polycystic Ovary Syndrome: Findings from a Lean Population. Eur. J. Clin. Investig. 51, e13417. https://10.1111/eci.13417
Matte, M. R., Del Río, J. P., Fernández, O., & Crisosto, N. (2024). Síndrome de Ovario Poliquístico y Salud Mental en Adolescentes. Andes pediátrica, 95(5). https://10.32641/andespediatr.v95i5.5229
Martínez Díaz, J. M. (2021). Efectos positivos del ejercicio sobre los síntomas y la calidad de vida de pacientes con síndrome de ovario poliquístico= Positive effects of exercice of the symptoms. https://dspace.unia.es/bitstream/handle/10334/6140/1153_Martínez.pdf?sequence=1&isAllowed=y
Mendoza, N., Galan, M. I., Molina, C., Mendoza-Tesarik, R., Conde, C., Mazheika, M., Diaz-Ropero, M. P., Fonolla, J., Tesarik, J. & Olivares, M. (2019). Dosis altas de D-chiro-inositol mejoran la calidad de los ovocitos en mujeres con síndrome de ovario poliquístico que se someten a ICSI: un ensayo controlado aleatorizado. Gynecological Endocrinology, 36(5), 398-401. https://doi.org/10.1080/09513590.2019.1681959
Mohan, A., Haider, R., Fakhor, H., Hina, F., Kumar, V., Jawed, A., Majumder, K., Ayaz, A., Lal, P. M., Tejwaney, U., Ram, N., & Kazeem, S. (2023). Vitamin D and polycystic ovary syndrome (PCOS): a review. Annals of medicine and surgery (2012), 85(7), 3506–3511. https://doi.org/10.1097/MS9.0000000000000879
Parker, J., O’Brien, C. y Hawrelak, J. (2022). A Narrative Review of the Role of Gastrointestinal Dysbiosis in the Pathogenesis of Polycystic Ovary Syndrome. Obstet. Gynecol. Sci. 65,14–28. https://10.5468/ogs.21185
Prabhu, Y. D. & Gopalakrishnan, V. D. (2021). Can polyunsaturated fatty acids regulate Polycystic Ovary Syndrome via TGF-β signalling? Life Sciences, 276, 119416. https://doi.org/10.1016/j.lfs.2021.119416
Quinga, S. M. & Tufiño, A. A. (2024). Vitamina D en el Síndrome de Ovario Poliquístico. MQRInvestigar, 8(2), 4120-4136. https://doi.org/10.56048/MQR20225.8.2.2024.4120-4136
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F. & Kumar, M. (2023). Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics. Journal of clinical medicine, 12(4), 1454. https://doi.org/10.3390/jcm12041454
Zhao, H., Zhang, J., Cheng, X. et al. (2023). Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res 16, 9. https://doi.org/10.1186/s13048-022-01091-0
Published
Issue
Section
License
Copyright (c) 2025 Atribución-NoComercial-SinDerivar 4.0 Internacional.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
.png)
.png)
